These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 10464170)

  • 1. Immunopathogenesis of hepatic fibrosis in chronic liver injury induced by repeatedly administered concanavalin A.
    Kimura K; Ando K; Ohnishi H; Ishikawa T; Kakumu S; Takemura M; Muto Y; Moriwaki H
    Int Immunol; 1999 Sep; 11(9):1491-500. PubMed ID: 10464170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strain difference in the induction of T-cell activation-associated, interferon gamma-dependent hepatic injury in mice.
    Mizuhara H; Kuno M; Seki N; Yu WG; Yamaoka M; Yamashita M; Ogawa T; Kaneda K; Fujii T; Senoh H; Fujiwara H
    Hepatology; 1998 Feb; 27(2):513-9. PubMed ID: 9462651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of tumor necrosis factor-α converting enzyme attenuates liver toxicity in a murine model of concanavalin A induced auto-immune hepatitis.
    Sharma M; Mohapatra J; Malik U; Wagh A; Singh A; Patel HM; Pandey D; Kadam S; Shah GB; Chatterjee A; Jain MR
    Int Immunopharmacol; 2013 Oct; 17(2):229-36. PubMed ID: 23816535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repeated concanavalin A challenge in mice induces an interleukin 10-producing phenotype and liver fibrosis.
    Louis H; Le Moine A; Quertinmont E; Peny MO; Geerts A; Goldman M; Le Moine O; Devière J
    Hepatology; 2000 Feb; 31(2):381-90. PubMed ID: 10655261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
    Xu W; Wang LW; Shi JZ; Gong ZJ
    Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible changes in expression of chemotaxin LECT2 mRNA in mouse liver after concanavalin A-induced hepatic injury.
    Segawa Y; Itokazu Y; Inoue N; Saito T; Suzuki K
    Biol Pharm Bull; 2001 Apr; 24(4):425-8. PubMed ID: 11305608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism of how anti-IL-18 prevents concanavalin-A-induced hepatic fibrosis on a mouse model.
    Zhang Y; Li P; Li G; Huang X; Meng Q; Lau WY; Wang X
    J Surg Res; 2007 Sep; 142(1):175-83. PubMed ID: 17559879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-22 ameliorates liver fibrogenesis by attenuating hepatic stellate cell activation and downregulating the levels of inflammatory cytokines.
    Lu DH; Guo XY; Qin SY; Luo W; Huang XL; Chen M; Wang JX; Ma SJ; Yang XW; Jiang HX
    World J Gastroenterol; 2015 Feb; 21(5):1531-45. PubMed ID: 25663772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of interferon gamma treatment on expression of TGF-beta1 and its receptors in liver fibrosis of mice with schistosomiasis japonica].
    Zhang BB; Jiao YW; Cai WM; Tao J; Liu RH
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2004 Dec; 22(6):340-3. PubMed ID: 15830858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interferon-beta reduces the mouse liver fibrosis induced by repeated administration of concanavalin A via the direct and indirect effects.
    Tanabe J; Izawa A; Takemi N; Miyauchi Y; Torii Y; Tsuchiyama H; Suzuki T; Sone S; Ando K
    Immunology; 2007 Dec; 122(4):562-70. PubMed ID: 17645499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis.
    Mizuhara H; Uno M; Seki N; Yamashita M; Yamaoka M; Ogawa T; Kaneda K; Fujii T; Senoh H; Fujiwara H
    Hepatology; 1996 Jun; 23(6):1608-15. PubMed ID: 8675184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of intrasinusoidal hemostasis in the development of concanavalin A-induced hepatic injury in mice.
    Miyazawa Y; Tsutsui H; Mizuhara H; Fujiwara H; Kaneda K
    Hepatology; 1998 Feb; 27(2):497-506. PubMed ID: 9462649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pirfenidone alleviates concanavalin A-induced liver fibrosis in mice.
    Salah MM; Ashour AA; Abdelghany TM; Abdel-Aziz AH; Salama SA
    Life Sci; 2019 Dec; 239():116982. PubMed ID: 31639402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon gamma plays a critical role in T cell-dependent liver injury in mice initiated by concanavalin A.
    Küsters S; Gantner F; Künstle G; Tiegs G
    Gastroenterology; 1996 Aug; 111(2):462-71. PubMed ID: 8690213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-fibrotic activity of sitagliptin against concanavalin A-induced hepatic fibrosis. Role of Nrf2 activation/NF-κB inhibition.
    Sharawy MH; El-Kashef DH; Shaaban AA; El-Agamy DS
    Int Immunopharmacol; 2021 Nov; 100():108088. PubMed ID: 34454288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
    Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
    J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-6, IFN-gamma and TNF-alpha production by liver-associated T cells and acute liver injury in rats administered concanavalin A.
    Cao Q; Batey R; Pang G; Russell A; Clancy R
    Immunol Cell Biol; 1998 Dec; 76(6):542-9. PubMed ID: 9893032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of cytokine gene polymorphism and hepatic transforming growth factor beta1 expression in recurrent hepatitis C after liver transplantation.
    Ben-Ari Z; Pappo O; Druzd T; Sulkes J; Klein T; Samra Z; Gadba R; Tambur AR; Tur-Kaspa R; Mor E
    Cytokine; 2004 Jul; 27(1):7-14. PubMed ID: 15207246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Sodium butyrate inhibits HMGB1 expression and release and attenuates concanavalin A-induced acute liver injury in mice].
    Gong Q; Chen MJ; Wang C; Nie H; Zhang YX; Shu KG; Li G
    Sheng Li Xue Bao; 2014 Oct; 66(5):619-24. PubMed ID: 25332009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-37 suppresses the sustained hepatic IFN-γ/TNF-α production and T cell-dependent liver injury.
    Feng XX; Chi G; Wang H; Gao Y; Chen Q; Ru YX; Luo ZL; Yan W; Li PY; Liu M; Feng ZH; Tian DA
    Int Immunopharmacol; 2019 Apr; 69():184-193. PubMed ID: 30735937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.